 | Up a level |
Doz, F., Locatelli, F., Baruchel, A., Blin, N., De Moerloose, B., Frappaz, D., Dworzak, M., Fischer, M., Stary, J., Riemann, K., Taube, T. and Reinhardt, D. (2016). Phase I Study to Evaluate Dose, Safety and Tolerability of the Polo-Like Kinase Inhibitor Volasertib in Paediatric Patients with Acute Leukaemia and Advanced Solid Tumours. Pediatr. Blood Cancer, 63. S. S8 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1545-5017
Johnson, M. L., Gort, E., Pant, S., Lolkema, M. P., Sebastian, M., Scheffler, M., Hwang, J., Duenzinger, U., Riemann, K., Kitzing, T. and Janne, P. A. (2021). A phase I, open-label, dose-escalation trial of BI 1701963 in patients (pts) with KRAS mutated solid tumours: A snapshot analysis. Ann. Oncol., 32. S. S591 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041